Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17151-17200 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02928978
Ruxolitinib for Premalignant Breast Disease
PHASE2Active, not recruiting
100 participants
Started: May 13, 2018 · Completed: Jun 30, 2026
4 conditions3 sponsors8 locations
NCT03965481
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer
NAActive, not recruiting
21 participants
Started: May 12, 2018 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT03730454
Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair
NAActive, not recruiting
142 participants
Started: May 11, 2018 · Completed: Feb 28, 2026
2 conditions1 sponsor10 locations
NCT03488394
Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant
PHASE1/PHASE2Active, not recruiting
8 participants
Started: May 11, 2018 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT03548961
Organ Preservation in Early Rectal Cancer Patients
PHASE2Active, not recruiting
19 participants
Started: May 11, 2018 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT03999151
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
NAActive, not recruiting
204 participants
Started: May 11, 2018 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT03652337
Meibomian Gland Dysfunction Management
NAActive, not recruiting
60 participants
Started: May 10, 2018 · Completed: Apr 10, 2019
2 conditions2 sponsors1 location
NCT03453567
Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
N/AActive, not recruiting
900 participants
Started: May 10, 2018 · Completed: Dec 15, 2030
2 conditions2 sponsors3 locations
NCT03444844
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
PHASE1/PHASE2Active, not recruiting
60 participants
Started: May 10, 2018 · Completed: Jul 31, 2022
2 conditions2 sponsors1 location
NCT03381872
Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease
NAActive, not recruiting
1,639 participants
Started: May 10, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03902600
A Study of Photon and Proton Chemoradiotherapy As Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer
N/AActive, not recruiting
103 participants
Started: May 10, 2018 · Completed: May 15, 2035
1 condition1 sponsor2 locations
NCT03473249
Effectiveness of Contrast-Enhanced Ultrasound
PHASE4Active, not recruiting
120 participants
Started: May 9, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03549442
Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
PHASE1Active, not recruiting
40 participants
Started: May 9, 2018 · Completed: Mar 31, 2036
1 condition2 sponsors1 location
NCT03593356
Baby's First Years
NAActive, not recruiting
1,000 participants
Started: May 9, 2018 · Completed: Aug 31, 2028
3 conditions11 sponsors1 location
NCT03531736
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
PHASE1Active, not recruiting
17 participants
Started: May 9, 2018 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT03533283
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2Active, not recruiting
211 participants
Started: May 8, 2018 · Completed: Oct 16, 2026
1 condition1 sponsor19 locations
NCT03381274
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
PHASE1/PHASE2Active, not recruiting
43 participants
Started: May 8, 2018 · Completed: Apr 16, 2026
1 condition1 sponsor13 locations
NCT03476330
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
PHASE2Active, not recruiting
48 participants
Started: May 8, 2018 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT03527719
China Rural Hypertension Control Project
NAActive, not recruiting
33,995 participants
Started: May 8, 2018 · Completed: Dec 31, 2026
1 condition9 sponsors1 location
NCT04329962
Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults
NAActive, not recruiting
12 participants
Started: May 8, 2018 · Completed: Jul 10, 2026
2 conditions1 sponsor1 location
NCT03511352
Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging
NAActive, not recruiting
78 participants
Started: May 8, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03495297
A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing
NAActive, not recruiting
965 participants
Started: May 7, 2018 · Completed: Jul 31, 2025
1 condition2 sponsors32 locations
NCT03418844
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NAActive, not recruiting
268 participants
Started: May 7, 2018 · Completed: Dec 31, 2025
3 conditions2 sponsors19 locations
NCT03558438
Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function
N/AActive, not recruiting
802 participants
Started: May 7, 2018 · Completed: May 31, 2025
2 conditions1 sponsor13 locations
NCT03604198
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
PHASE2Active, not recruiting
125 participants
Started: May 7, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor48 locations
NCT03673293
Measuring Postoperative Mobility, Gait Symmetry and Feedback Following TJA
N/AActive, not recruiting
150 participants
Started: May 5, 2018 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT03386734
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
NAActive, not recruiting
989 participants
Started: May 3, 2018 · Completed: May 31, 2029
1 condition3 sponsors106 locations
NCT03441113
Extended Access of Momelotinib in Adults With Myelofibrosis
PHASE2Active, not recruiting
237 participants
Started: May 3, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor224 locations
NCT03469960
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
PHASE3Active, not recruiting
265 participants
Started: May 2, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor47 locations
NCT03500328
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAActive, not recruiting
900 participants
Started: May 2, 2018 · Completed: Aug 1, 2026
1 condition3 sponsors47 locations
NCT03428477
EPA for Metastasis Trial 2
PHASE3Active, not recruiting
418 participants
Started: May 2, 2018 · Completed: Apr 30, 2026
2 conditions3 sponsors13 locations
NCT03401788
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
PHASE2Active, not recruiting
50 participants
Started: May 2, 2018 · Completed: Mar 29, 2026
6 conditions1 sponsor11 locations
NCT03483012
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
PHASE2Active, not recruiting
6 participants
Started: May 1, 2018 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05247632
Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study
N/AActive, not recruiting
2,290 participants
Started: May 1, 2018 · Completed: Jul 1, 2028
1 condition3 sponsors2 locations
NCT05685810
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
N/AActive, not recruiting
3,029 participants
Started: May 1, 2018 · Completed: Jan 31, 2030
7 conditions23 sponsors1 location
NCT03522831
CF Bronchodilation
NAActive, not recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03708952
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
N/AActive, not recruiting
25,000 participants
Started: May 1, 2018 · Completed: May 1, 2028
2 conditions3 sponsors2 locations
NCT03278119
Sleep Aging and Risk for Alzheimer's 2.0
N/AActive, not recruiting
158 participants
Started: May 1, 2018 · Completed: Dec 25, 2025
2 conditions2 sponsors1 location
NCT03539575
CB1R in Synthetic Psychoactive Cannabinoids
NAActive, not recruiting
15 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT03745521
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
N/AActive, not recruiting
226 participants
Started: May 1, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03422393
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
PHASE1Active, not recruiting
24 participants
Started: May 1, 2018 · Completed: Aug 31, 2028
2 conditions2 sponsors1 location
NCT02645266
Mean Visual Acuity Changes Following Five Injections of Aflibercept
NAActive, not recruiting
48 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03834844
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
NAActive, not recruiting
50 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03400085
Pilot Study of an mHealth Intervention for Living Donor Follow-up
NAActive, not recruiting
400 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
3 conditions4 sponsors2 locations
NCT03523312
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
PHASE2Active, not recruiting
47 participants
Started: Apr 30, 2018 · Completed: Apr 30, 2026
1 condition1 sponsor8 locations
NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
PHASE3Active, not recruiting
173 participants
Started: Apr 30, 2018 · Completed: Jun 30, 2026
4 conditions2 sponsors43 locations
NCT03419481
Pembrolizumab in Hepatocellular Carcinoma
PHASE2Active, not recruiting
30 participants
Started: Apr 30, 2018 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
PHASE2Active, not recruiting
46 participants
Started: Apr 30, 2018 · Completed: Mar 31, 2026
5 conditions5 sponsors4 locations
NCT03449108
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
PHASE2Active, not recruiting
30 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2027
16 conditions3 sponsors1 location
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
PHASE2Active, not recruiting
196 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2026
4 conditions2 sponsors29 locations